STOCK MARKET BLOG AUGUST 2023

by the CEO Silvano Grimaldi of the independent asset management company GRIMALDI & PARTNERS AG

MONTHLY REVIEW

The international stock markets ended the month of AUGUST with slight losses.

BURDENING FACTORS

Downgrading by the rating agency Fitch, which lowered the USA's coveted top credit rating by one step from "AAA" to "AA+".
Concerns about the global economy and especially the Chinese economy continue to dominate events.
Capital market interest rates continue to rise.

EQUITIES IN FOCUS

ROCHE reports positive Phase 3 clinical results

Phase 3 ALINA trial of Alecensa in early lung cancer meets primary endpoint of disease-free survival.

This further strengthens Roche's market position as the global number 1 in cancer research.

MONTHLY OUTLOOK

The stock markets should continue the slump during the statistically weak summer months until the beginning of October. The expectation of an end to the interest rate hike cycle by the US Federal Reserve will have a positive impact on stock prices. On the other hand, the expectation of an economic recession, albeit a short one, has a slowing effect.

We don't expect any big jumps over the weeks of September.

STOCK RECOMMENDATION: ROCHE